NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE50723 Query DataSets for GSE50723
Status Public on Dec 16, 2013
Title Whole genome mapping of STAT3 binding sites in the two major subtypes of diffuse large B cell lymphoma
Organism Homo sapiens
Experiment type Genome binding/occupancy profiling by high throughput sequencing
Summary The goal of this study is to identify the effect of the transcription factor STAT3 in the two major subtypes of diffuse large B cell lymphoma (DLBCL). STAT3 is a signal transducer that, when dysregulated, becomes a powerful oncogene found in many human cancers, including DLBCL. DLBCL is the most common form of non-Hodgkin’s lymphoma and has two major subtypes: germinal center B-cell-like (GCB) and activated B-cell-like (ABC). When compared to the GCB form, ABC lymphomas respond much more poorly to current therapies and often exhibit overexpression or overactivation of STAT3. To investigate how STAT3 might contribute to this aggressive phenotype, we have used ChIP-Seq to identify STAT3 binding sites in 8 DLBCL cell lines (4 GCB subtype, 4 ABC) that are derived from patient tumors. 10,337 distinct STAT3 binding regions are occupied in at least two of the eight cell lines. One third (n = 3524) are differentially bound by STAT3 between the two subtypes (FDR < 0.05). More BRs are strongly bound in ABC than in GCB: 44% of differentially bound BRs (n = 1550) show more STAT3 binding in GCB, while 56% (n = 1974) are more strongly bound in ABC.
 
Overall design Identification and comparison of STAT3 transcription factor binding sites in 8 cell lines that represent the 2 subtypes of DLBCL. 4 cell lines are subtyped as ABC and 4 are subtyped as GCB. 2-9 replicates and 1 input control are present for each cell line. (Cell line OCI-Ly19 was not included in the final analysis because RNA-Seq showed that its gene expression clustered in between the subtypes, probably due to its EBV+ status. However, its peak calls were used in intermediate steps of the analysis pipeline. Its sequencing runs have been included for completeness.)
 
Contributor(s) Hardee JM, Ouyang Z, Zhang Y, Kundaje A, Lacroute P, Snyder MP
Citation(s) 24142927
Submission date Sep 10, 2013
Last update date May 15, 2019
Contact name Jennifer Marion Hardee
E-mail(s) jenn.hardee@gmail.com
Organization name Stanford University
Street address 300 Pasteur Dr., M-344
City Stanford
State/province California
ZIP/Postal code 94305
Country USA
 
Platforms (1)
GPL10999 Illumina Genome Analyzer IIx (Homo sapiens)
Samples (18)
GSM1227204 OCI-Ly10_ChIPSeq
GSM1227205 OCI-Ly19_ChIPSeq
GSM1227206 OCI-Ly3_ChIPSeq
This SubSeries is part of SuperSeries:
GSE50724 Correlation between STAT3 binding presence and gene expression levels in subtypes of diffuse large B cell lymphoma
Relations
BioProject PRJNA218584
SRA SRP029740

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE50723_ChIPSeq_AssociatedGenes.txt.gz 396.1 Kb (ftp)(http) TXT
GSE50723_ChIPSeq_ReadCountsByReplicate.txt.gz 780.3 Kb (ftp)(http) TXT
GSE50723_ChIPSeq_STAT3BindingRegions.txt.gz 90.6 Kb (ftp)(http) TXT
GSE50723_ChIPSeq_StatisticalResults.txt.gz 238.6 Kb (ftp)(http) TXT
GSE50723_RAW.tar 1.0 Mb (http)(custom) TAR (of BED)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap